Ablexis LLC

Industry

  • Biotechnology
    • Drug Discovery Technologies
    • Transgenics
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
See more in Biomedtracker

Latest on Ablexis LLC

Scrip

Deal Watch: Amgen Taps Plexium's Expertise In Targeted Protein Degradation

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Amgen, Plexium Team Up Against Challeng

Scrip

Tech Transfer Roundup: Amicus Adds Gene Therapy Technology In UPenn Partnership

 
• By Joseph Haas and Jung Won Shin

Below is Scrip’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Amicus,

Scrip

Deal Watch: Teva's Sol Barer Leads Buyout Of IO Start-up NexImmune

 
• By Joseph Haas, Ian Haydock, Ying Huang, John Davis, and Sten Stovall

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions that occurred between Feb. 13 and 2

In Vivo

Deals Shaping The Medical Industry, March 2017

 
• By Steven Muntner, Beth Allan, Deanna Kamienski, Amanda Micklus, and Maureen Riordan

IN VITRO DIAGNOSTICS Financings Vermillion Inc. Vermillion Inc. grossed $5.6mm through the private sale of 3.75mm common shares at $1.40 (a 6% premium). Investors also received five-year warrants